Description
TREVIAMET Tablets 50mg+1000mg are a powerful prescription combination medication available at Gathimaini Pharmacy in Thika, Kenya, indicated for the comprehensive management of Type 2 Diabetes Mellitus. Each tablet contains Sitagliptin 50mg and Metformin Hydrochloride 1000mg.
This combination medication works through two complementary mechanisms to effectively lower elevated blood sugar levels:
- Sitagliptin (a dipeptidyl peptidase-4, or DPP-4, inhibitor) helps the body increase its levels of natural substances called incretins, which in turn promote the pancreas to release more insulin when blood sugar is high and reduce the liver’s production of glucose.
- Metformin (a biguanide) primarily reduces the amount of glucose produced by the liver, decreases the absorption of glucose from the intestines, and improves the body’s sensitivity to insulin.
TREVIAMET 50mg+1000mg is typically prescribed as an adjunct to diet and exercise to improve glycemic control in adult patients with Type 2 Diabetes, particularly when their condition is not adequately controlled by metformin alone, or by other single therapies. It can also be used in patients already taking both components as separate tablets. This combination provides robust control of both fasting and post-meal blood sugar, helping to prevent long-term complications associated with diabetes. Common pack sizes include 14, 28, or 35 tablets.
